Breast cancer stem cells: an update
- PMID: 23322821
- DOI: 10.1136/jclinpath-2012-201304
Breast cancer stem cells: an update
Abstract
Breast cancer is a significant cause of morbidity and mortality in women with a high incidence of recurrence or treatment failure. Growing evidence suggests that cancer stem cells (CSCs) most likely contribute to tumour progression, spread and therapy failure. However, despite extensive research and the tremendous clinical potential of such cells in possible therapeutic management, the real nature of CSCs remains an enigma. In this review, we discuss the fundamental properties and molecular target of CSCs and focus on recent advances regarding the identification of CSC markers with emphasis on breast cancer and the underlying molecular mechanism of CSC phenotypes. We also discuss experimental evidence of targeting molecular pathways in order to modulate breast CSC behaviour in tumourigenesis and the controversies associated with it that potentially weaken the CSC model in breast cancer and other cancers as well.
Keywords: Breast Cancer; Cancer Stem Cells; Molecular Oncology.
Similar articles
-
MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.Cancer Gene Ther. 2012 Nov;19(11):723-30. doi: 10.1038/cgt.2012.58. Epub 2012 Sep 14. Cancer Gene Ther. 2012. PMID: 22975591 Review.
-
Breast-cancer stem cells-beyond semantics.Lancet Oncol. 2012 Jan;13(1):e43-8. doi: 10.1016/S1470-2045(11)70191-7. Lancet Oncol. 2012. PMID: 22225725 Review.
-
Distribution of cancer stem cells in ductal invasive carcinoma of breast (review).Georgian Med News. 2013 Sep;(222):44-50. Georgian Med News. 2013. PMID: 24099814 Review.
-
Recurrence and metastasis of breast cancer is influenced by ovarian hormone's effect on breast cancer stem cells.Future Oncol. 2015;11(6):983-95. doi: 10.2217/fon.14.301. Future Oncol. 2015. PMID: 25760978 Review.
-
MicroRNAs and cancer stem cells: therapeutic approaches and future perspectives.Cancer Lett. 2013 Sep 10;338(1):174-83. doi: 10.1016/j.canlet.2012.04.020. Epub 2012 Apr 30. Cancer Lett. 2013. PMID: 22554710 Review.
Cited by
-
Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cells.Int J Cancer. 2015 Oct 1;137(7):1610-20. doi: 10.1002/ijc.29542. Epub 2015 Apr 27. Int J Cancer. 2015. PMID: 25833198 Free PMC article.
-
A multiple breast cancer stem cell model to predict recurrence of T1-3, N0 breast cancer.BMC Cancer. 2019 Jul 24;19(1):729. doi: 10.1186/s12885-019-5941-5. BMC Cancer. 2019. PMID: 31340763 Free PMC article.
-
Sumoylation pathway is required to maintain the basal breast cancer subtype.Cancer Cell. 2014 Jun 16;25(6):748-61. doi: 10.1016/j.ccr.2014.04.008. Epub 2014 May 15. Cancer Cell. 2014. PMID: 24835590 Free PMC article.
-
Differential CD133 expression distinguishes malignant from benign papillary lesions of the breast.Virchows Arch. 2015 Feb;466(2):177-84. doi: 10.1007/s00428-014-1695-2. Epub 2014 Nov 30. Virchows Arch. 2015. PMID: 25433813
-
Morusin inhibits human cervical cancer stem cell growth and migration through attenuation of NF-κB activity and apoptosis induction.Mol Cell Biochem. 2013 Jul;379(1-2):7-18. doi: 10.1007/s11010-013-1621-y. Epub 2013 Mar 31. Mol Cell Biochem. 2013. PMID: 23543150
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous